USA - Warnex Receives NPIP Approval for Salmonella Test
Published: October 9, 2006
Source : Warnex Inc.
The objective of the National Poultry Improvement Plan is to provide a cooperative industry-state-federal program through which new technology can be effectively applied to the improvement of poultry and poultry products. The plan consists of a variety of programs intended to prevent and control poultry diseases.
The Warnex Salmonella test for environmental samples was independently validated by NPIP-approved laboratories, which concluded that the Warnex test performed as well as or better than the two NPIP-approved microbiological reference methods. In addition, the test performed just as well with pooled samples, which can increase a plant's testing efficiency and significantly reduce testing costs.
"Our new sample pooling feature clearly illustrates our commitment to innovation aimed at improving our clients' efficiency," said Mark Busgang, President and CEO of Warnex. "This, in addition to NPIP approval which provides further regulatory and scientific validation of our tests, will help reduce the barrier to entry for major poultry clients and encourage adoption."
The Warnex Rapid Pathogen Detection System offers a versatile detection and quantification platform, using real-time PCR technology combined with proprietary genetic markers and software, to rapidly and accurately determine the presence of pathogens in a sample. The system allows for the simultaneous detection of multiple pathogens and processing of samples within 3 to 48 hours, a significant improvement over traditional microbiology tests that require 5 to 7 days.
According to the U.S. Centers for Disease Control and Prevention (CDC), an estimated 1.4 million cases and 500 deaths occur in the United States annually due to Salmonella infections. Salmonellosis, an infection caused by eating food contaminated with Salmonella, causes symptoms such as diarrhea, fever, vomiting and abdominal cramps, lasting usually 4 to 7 days. In some cases, it may cause blood infection and even death, if untreated.
About Warnex
Warnex is a biotechnology company devoted to protecting public health by providing advanced diagnostic products and science-based services to the agri-food, pharmaceutical and healthcare sectors. Warnex's DNA-based technology offers a versatile detection platform that produces accurate results rapidly, using Real-Time PCR technology combined with unique genetic markers and software. With a focus on pathogen detection in food, our development pipeline also includes applications in GMO testing and meat speciation, as well as in the detection of viruses, yeasts and moulds. Warnex's analytical, bioanalytical, and medical laboratory service groups offer a variety of quality control services, method development and validation, contract R&D, bioavailability and bioequivalence studies for clinical trials, and medical laboratory testing.
Warnex is a trademark of Warnex Inc., Laval, Quebec.
Source
Warnex Inc.Related topics:
Recommend
Share
Would you like to discuss another topic? Create a new post to engage with experts in the community.
Featured users in Poultry Industry
Shivaram Rao
Pilgrim´s
PhD Director Principal de Nutrición y Servicios Técnicos de Pilgrim’s Pride Corporation
United States
United States
